Literature DB >> 20694512

Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis.

Nirav Thosani1, Sonali Thosani, Wei Qiao, Jason B Fleming, Manoop S Bhutani, Sushovan Guha.   

Abstract

BACKGROUND: Preoperative diagnosis of malignancy in pancreatic cystic lesions (PCLs) remains challenging. Most non-mucinous cystic lesions (NMCLs) are benign, but mucinous cystic lesions (MCLs) are more likely to be premalignant or malignant. AIM: The aim of this study was to assess the sensitivity, specificity, and positive and negative likelihood ratios (LRs) of EUS-FNA-based cytology in differentiating MCLs from non-mucinous PCLs.
METHODS: We conducted a comprehensive search of MEDLINE, SCOPUS, Cochrane, and "CINAHL Plus" databases to identify studies, in which the results of EUS-FNA-based cytology of PCLs were compared with those of surgical biopsy or surgical excision histopathology. A DerSimonian-Laird random effect model was used to estimate the pooled sensitivity, specificity, and LRs, and a summary receiver-operating characteristic (SROC) curve was constructed.
RESULTS: We included 376 patients from 11 distinct studies who underwent EUS-FNA-based cytology and also had histopathological diagnosis. The pooled sensitivity and specificity in diagnosing MCLs were 0.63 (95% CI, 0.56-0.70) and 0.88 (95% CI, 0.83-0.93), respectively. The positive and negative LRs in diagnosing MCLs were 4.46 (95% CI, 1.21-16.43) and 0.46 (95% CI, 0.25-0.86), respectively. The area under the curve (AUC) was 0.89.
CONCLUSIONS: EUS-FNA-based cytology has overall low sensitivity but good specificity in differentiating MCLs from NMCLs. Further research is required to improve the overall sensitivity of EUS-FNA-based cytology to diagnose MCLs while evaluating PCL.

Entities:  

Mesh:

Year:  2010        PMID: 20694512      PMCID: PMC4169146          DOI: 10.1007/s10620-010-1361-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

1.  Exploring sources of heterogeneity in systematic reviews of diagnostic tests.

Authors:  Jeroen G Lijmer; Patrick M M Bossuyt; Siem H Heisterkamp
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 3.  Management of cystic neoplasms of the pancreas.

Authors:  J C Box; H O Douglas
Journal:  Am Surg       Date:  2000-05       Impact factor: 0.688

4.  Utility of EUS in the evaluation of cystic pancreatic lesions.

Authors:  Robert Sedlack; Aboud Affi; Enrique Vazquez-Sequeiros; Ian D Norton; Jonathan E Clain; Maurits J Wiersema
Journal:  Gastrointest Endosc       Date:  2002-10       Impact factor: 9.427

Review 5.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

6.  Role of endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration in the diagnosis and treatment of cystic lesions of the pancreas.

Authors:  Lyndon V Hernandez; Girish Mishra; Christopher Forsmark; Peter V Draganov; John M Petersen; Steven N Hochwald; Stephen B Vogel; Manoop S Bhutani
Journal:  Pancreas       Date:  2002-10       Impact factor: 3.327

7.  Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms?

Authors:  M G Sarr; H A Carpenter; L P Prabhakar; T F Orchard; S Hughes; J A van Heerden; E P DiMagno
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

8.  CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment?

Authors:  C A Curry; J Eng; K M Horton; B Urban; S Siegelman; B S Kuszyk; E K Fishman
Journal:  AJR Am J Roentgenol       Date:  2000-07       Impact factor: 3.959

9.  Endoscopic ultrasound characteristics of mucinous cystic neoplasms of the pancreas.

Authors:  F Gress; K Gottlieb; O Cummings; S Sherman; G Lehman
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

10.  Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.

Authors:  Asif Khalid; Maliha Zahid; Sydney D Finkelstein; Julia K LeBlanc; Neeraj Kaushik; Nuzhat Ahmad; William R Brugge; Steven A Edmundowicz; Robert H Hawes; Kevin M McGrath
Journal:  Gastrointest Endosc       Date:  2009-01-18       Impact factor: 9.427

View more
  40 in total

1.  Pancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle.

Authors:  Luca Barresi; Ilaria Tarantino; Antonino Granata; Gabriele Curcio; Mario Traina
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

Review 2.  Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review.

Authors:  Jiong Chen; Renbao Yang; Yin Lu; Yunlian Xia; Hangcheng Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-30       Impact factor: 4.553

3.  Should pancreas cyst fluids be divided into two for cytological diagnosis and biochemical tests?

Authors:  Davut Şahin; Bahattin Çiçek; İlkser Akpolat; Gürhan Şişman; Nilgün Tekkeşin
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

4.  Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.

Authors:  Ji Kon Ryu; Hanno Matthaei; Marco Dal Molin; Seung-Mo Hong; Marcia I Canto; Richard D Schulick; Christopher Wolfgang; Michael G Goggins; Ralph H Hruban; Leslie Cope; Anirban Maitra
Journal:  Pancreatology       Date:  2011-07-12       Impact factor: 3.996

Review 5.  To cease or 'de-cyst'? The evaluation and management of pancreatic cystic lesions.

Authors:  Brintha K Enestvedt; Nuzhat Ahmad
Journal:  Curr Gastroenterol Rep       Date:  2013-10

Review 6.  Novel Biomarkers for Pancreatic Cysts.

Authors:  Harkirat Singh; Kevin McGrath; Aatur D Singhi
Journal:  Dig Dis Sci       Date:  2017-02-14       Impact factor: 3.199

Review 7.  Does EUS-FNA molecular analysis carry additional value when compared to cytology in the diagnosis of pancreatic cystic neoplasm? A systematic review.

Authors:  Amy Gillis; Ilaria Cipollone; Grainne Cousins; Kevin Conlon
Journal:  HPB (Oxford)       Date:  2014-11-27       Impact factor: 3.647

Review 8.  Managing Incidental Pancreatic Cysts.

Authors:  Jennifer Phan; V Raman Muthusamy
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

Review 9.  Endoscopic Management of Pancreatic Cysts.

Authors:  Michael J Bartel; Massimo Raimondo
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 10.  The Role of Endoscopic Ultrasound in the Diagnosis of Cystic Lesions of the Pancreas.

Authors:  Philippe Lévy; Vinciane Rebours
Journal:  Visc Med       Date:  2018-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.